These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34611265)

  • 1. Ileal mucosa-associated microbiota overgrowth associated with pathogenesis of primary biliary cholangitis.
    Kitahata S; Yamamoto Y; Yoshida O; Tokumoto Y; Kawamura T; Furukawa S; Kumagi T; Hirooka M; Takeshita E; Abe M; Ikeda Y; Hiasa Y
    Sci Rep; 2021 Oct; 11(1):19705. PubMed ID: 34611265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive Analysis of Serum and Fecal Bile Acid Profiles and Interaction with Gut Microbiota in Primary Biliary Cholangitis.
    Chen W; Wei Y; Xiong A; Li Y; Guan H; Wang Q; Miao Q; Bian Z; Xiao X; Lian M; Zhang J; Li B; Cao Q; Fan Z; Zhang W; Qiu D; Fang J; Gershwin ME; Yang L; Tang R; Ma X
    Clin Rev Allergy Immunol; 2020 Feb; 58(1):25-38. PubMed ID: 30900136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Salivary Microbiota of Patients With Primary Biliary Cholangitis Is Distinctive and Pathogenic.
    Lv L; Jiang H; Chen X; Wang Q; Wang K; Ye J; Li Y; Fang D; Lu Y; Yang L; Gu S; Chen J; Diao H; Yan R; Li L
    Front Immunol; 2021; 12():713647. PubMed ID: 34367180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy.
    Tang R; Wei Y; Li Y; Chen W; Chen H; Wang Q; Yang F; Miao Q; Xiao X; Zhang H; Lian M; Jiang X; Zhang J; Cao Q; Fan Z; Wu M; Qiu D; Fang JY; Ansari A; Gershwin ME; Ma X
    Gut; 2018 Mar; 67(3):534-541. PubMed ID: 28213609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation of mucosa-associated microbiota dysbiosis in the ascending colon in hepatitis C virus post-sustained virologic response cirrhotic patients.
    Midori Y; Nosaka T; Hiramatsu K; Akazawa Y; Tanaka T; Takahashi K; Naito T; Matsuda H; Ohtani M; Nakamoto Y
    Front Cell Infect Microbiol; 2024; 14():1371429. PubMed ID: 38650735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbial profile of treatment-naive patients with primary biliary cholangitis.
    Zhou YJ; Ying GX; Dong SL; Xiang B; Jin QF
    Front Immunol; 2023; 14():1126117. PubMed ID: 37223092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of butyric acid-producing bacteria in the ileal mucosa-associated microbiota is associated with the history of abdominal surgery in patients with Crohn's disease.
    Handa O; Miura H; Gu T; Osawa M; Matsumoto H; Umegaki E; Inoue R; Naito Y; Shiotani A
    Redox Rep; 2023 Dec; 28(1):2241615. PubMed ID: 37530134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring Advanced Therapies for Primary Biliary Cholangitis: Insights from the Gut Microbiota-Bile Acid-Immunity Network.
    Guo Z; He K; Pang K; Yang D; Lyu C; Xu H; Wu D
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysbiosis of the Duodenal Mucosal Microbiota Is Associated With Increased Small Intestinal Permeability in Chronic Liver Disease.
    Raj AS; Shanahan ER; Tran CD; Bhat P; Fletcher LM; Vesey DA; Morrison M; Holtmann G; Macdonald GA
    Clin Transl Gastroenterol; 2019 Aug; 10(8):e00068. PubMed ID: 31373933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal microbiota in biliary diseases.
    Xia Q; Liu Q; Ma X
    Curr Opin Gastroenterol; 2023 Mar; 39(2):95-102. PubMed ID: 36821457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysbiosis of oral microbiota and its association with salivary immunological biomarkers in autoimmune liver disease.
    Abe K; Takahashi A; Fujita M; Imaizumi H; Hayashi M; Okai K; Ohira H
    PLoS One; 2018; 13(7):e0198757. PubMed ID: 29969462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Management of Primary Biliary Cholangitis-Strategies and Evolving Trends.
    Gao L; Wang L; Woo E; He X; Yang G; Bowlus C; Leung PSC; Gershwin ME
    Clin Rev Allergy Immunol; 2020 Oct; 59(2):175-194. PubMed ID: 31713023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma cells and the chronic nonsuppurative destructive cholangitis of primary biliary cirrhosis.
    Takahashi T; Miura T; Nakamura J; Yamada S; Miura T; Yanagi M; Matsuda Y; Usuda H; Emura I; Tsuneyama K; He XS; Gershwin ME
    Hepatology; 2012 Mar; 55(3):846-55. PubMed ID: 22031474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotyping and auto-antibody production by liver-infiltrating B cells in primary sclerosing cholangitis and primary biliary cholangitis.
    Chung BK; Guevel BT; Reynolds GM; Gupta Udatha DB; Henriksen EK; Stamataki Z; Hirschfield GM; Karlsen TH; Liaskou E
    J Autoimmun; 2017 Feb; 77():45-54. PubMed ID: 27784538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of langerhans cell infiltrate by CD1a immunostain in liver biopsy for the diagnosis of primary biliary cirrhosis.
    Graham RP; Smyrk TC; Zhang L
    Am J Surg Pathol; 2012 May; 36(5):732-6. PubMed ID: 22498823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autotaxin, bile acid profile and effect of ileal bile acid transporter inhibition in primary biliary cholangitis patients with pruritus.
    Hegade VS; Pechlivanis A; McDonald JAK; Rees D; Corrigan M; Hirschfield GM; Taylor-Robinson SD; Holmes E; Marchesi JR; Kendrick S; Jones DE
    Liver Int; 2019 May; 39(5):967-975. PubMed ID: 30735608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin 23 Produced by Hepatic Monocyte-Derived Macrophages Is Essential for the Development of Murine Primary Biliary Cholangitis.
    Reuveni D; Brezis MR; Brazowski E; Vinestock P; Leung PSC; Thakker P; Gershwin ME; Zigmond E
    Front Immunol; 2021; 12():718841. PubMed ID: 34484224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased infiltration of CD4
    Yu K; Li P; Xu T; Xu J; Wang K; Chai J; Zhao D; Liu Y; Wang Y; Ma J; Fan L; Guo S; Li Z; Li M; Wang Z
    Pathol Res Pract; 2021 Jan; 217():153291. PubMed ID: 33249399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL23R-Protective Coding Variant Promotes Beneficial Bacteria and Diversity in the Ileal Microbiome in Healthy Individuals Without Inflammatory Bowel Disease.
    Zakrzewski M; Simms LA; Brown A; Appleyard M; Irwin J; Waddell N; Radford-Smith GL
    J Crohns Colitis; 2019 Mar; 13(4):451-461. PubMed ID: 30445599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A disease-specific decline of the relative abundance of Bifidobacterium in patients with autoimmune hepatitis.
    Liwinski T; Casar C; Ruehlemann MC; Bang C; Sebode M; Hohenester S; Denk G; Lieb W; Lohse AW; Franke A; Schramm C
    Aliment Pharmacol Ther; 2020 Jun; 51(12):1417-1428. PubMed ID: 32383181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.